University of Cambridge is currently accepting applications for its Discovery of Rational Therapeutic Biomarkers in Breast Cancer Scholarship 2027 in UK. Intersted applicants are encouraged to click here to learn more about this opportunity and apply for it.
About University of Cambridge - Discovery of Rational Therapeutic Biomarkers in Breast Cancer Scholarship
Discovery of rational therapeutic biomarkers in breast cancer scholarship by systems pathology and deep learning offering training in spatial cancer biology, multiomic spatial methods and deep learning applied to breast cancer tissue datasets. The studentship is based at the Cancer Research UK Cambridge Institute within the University of Cambridge. The project is supervised by Dr Hamid Raza Ali and the Ali Lab, and further details and publications are available via the Ali Lab website and the University Applicant Portal.
Benefits of University of Cambridge - Discovery of Rational Therapeutic Biomarkers in Breast Cancer Scholarship
- This is a fully-funded PhD studentship (title indicates Fully-funded).
- You will receive extensive training in cancer pathology, highly multiplexed imaging, and predictive modelling.
- Opportunity to develop expertise in quantitative pathology in the field of spatial cancer biology.
- Work within a diverse and collaborative group spanning clinicians, pathologists, computational and cancer biologists.
University of Cambridge - Discovery of Rational Therapeutic Biomarkers in Breast Cancer Scholarship Requirements
- Applications are invited from graduates in quantitative disciplines such as computer science, AI, and mathematics.
- Applications are also encouraged from biologists and clinicians already experienced in computational methods.
Application Date and Process
- Click on the link to the application website to apply.
Application Deadline
16 October, 2026
Opportunity Application
View details of
University of Cambridge - Discovery of Rational Therapeutic Biomarkers in Breast Cancer Scholarship
Apply for University of Cambridge - Discovery of Rational Therapeutic Biomarkers in Breast Cancer Scholarship